Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-01-05 @ 5:30 PM
Study NCT ID:
NCT02035956
Status:
COMPLETED
Last Update Posted:
2020-01-18
First Post:
2014-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IVAC MUTANOME Phase I Clinical Trial
Sponsor:
BioNTech RNA Pharmaceuticals GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
ACTUAL
Primary Completion Date:
2017-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-10
First Submit QC Date:
None
Study First Post Date:
2014-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-14
Last Update Post Date:
2020-01-18
Last Update Post Date Type:
ACTUAL